Literature DB >> 18723495

Cellular commitment to reentry into the cell cycle after stalled DNA is determined by site-specific phosphorylation of Chk1 and PTEN.

Sarah A Martin1, Toru Ouchi.   

Abstract

In this study, we show that depletion of Chk1 by small interfering RNA (siRNA) results in failure of reentry to the cell cycle after DNA replication has been stalled by exposure to hydroxyurea (HU). Casein kinase II (CKII) is degraded in these cells in a proteasome-dependent manner, resulting in decreased phosphorylation and PTEN levels. We show that phosphorylation of Chk1 at Ser(317) but not at Ser(345) is required for phosphorylation of PTEN at Thr(383) by CKII, making cell cycle reentry after HU treatment possible. Like Chk1 depletion, loss of PTEN due to siRNA is followed by inability to return to the cell cycle following HU. In Chk1-siRNA cells, reintroduction of wild-type PTEN but not PTEN T383A restores the ability of the cell to reenter the G(2)-M phase of the cell cycle after stalled DNA replication. We conclude that, in response to stalled DNA replication, Chk1 is phosphorylated at Ser(317) by ATR resulting in stabilization of CKII, which in turn leads to phosphorylation of PTEN at Thr(383).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723495      PMCID: PMC4979322          DOI: 10.1158/1535-7163.MCT-08-0199

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  23 in total

1.  The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.

Authors:  J Torres; R Pulido
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

Review 2.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

3.  Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance.

Authors:  Eric J Brown; David Baltimore
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

4.  Phosphorylation of the regulatory beta-subunit of protein kinase CK2 by checkpoint kinase Chk1: identification of the in vitro CK2beta phosphorylation site.

Authors:  Lars P Kristensen; Martin R Larsen; Peter Højrup; Olaf-Georg Issinger; Barbara Guerra
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

5.  Rapid activation of ATR by ionizing radiation requires ATM and Mre11.

Authors:  Jeremy S Myers; David Cortez
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

6.  The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.

Authors:  Claus Storgaard Sørensen; Lasse Tengbjerg Hansen; Jaroslaw Dziegielewski; Randi G Syljuåsen; Cecilia Lundin; Jiri Bartek; Thomas Helleday
Journal:  Nat Cell Biol       Date:  2005-01-23       Impact factor: 28.824

7.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

8.  Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation.

Authors:  J Y Ahn; J K Schwarz; H Piwnica-Worms; C E Canman
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

9.  CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers.

Authors:  F Bertoni; A M Codegoni; D Furlan; M G Tibiletti; C Capella; M Broggini
Journal:  Genes Chromosomes Cancer       Date:  1999-10       Impact factor: 5.006

10.  Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.

Authors:  Barbara Guerra; Olaf-Georg Issinger; Jean Y J Wang
Journal:  Oncogene       Date:  2003-08-07       Impact factor: 9.867

View more
  10 in total

Review 1.  PTEN in DNA damage repair.

Authors:  Mei Ming; Yu-Ying He
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

2.  Abortive cell cycle events in the brains of scrapie-infected hamsters with remarkable decreases of PLK3/Cdc25C and increases of PLK1/cyclin B1.

Authors:  Hui Wang; Chan Tian; Yin Xu; Wu-Ling Xie; Jin Zhang; Bao-Yun Zhang; Ke Ren; Ke Wang; Cao Chen; Shao-Bin Wang; Qi Shi; Qi-Xiang Shao; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

Review 3.  Cell Cycle Control by PTEN.

Authors:  Andrew Brandmaier; Sheng-Qi Hou; Wen H Shen
Journal:  J Mol Biol       Date:  2017-06-09       Impact factor: 5.469

4.  Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.

Authors:  P O Carminati; F S Donaires; M M Marques; E A Donadi; G A S Passos; E T Sakamoto-Hojo
Journal:  Mol Biol Rep       Date:  2013-11-12       Impact factor: 2.316

Review 5.  PTEN, Longevity and Age-Related Diseases.

Authors:  Izak S Tait; Yan Li; Jun Lu
Journal:  Biomedicines       Date:  2013-12-13

6.  Chk1 Promotes DNA Damage Response Bypass following Oxidative Stress in a Model of Hydrogen Peroxide-Associated Ulcerative Colitis through JNK Inactivation and Chromatin Binding.

Authors:  Kathrin Reissig; Andrew Silver; Roland Hartig; Antje Schinlauer; Diana Walluscheck; Thomas Guenther; Sandra Siedentopf; Jochen Ross; Diep-Khanh Vo; Albert Roessner; Angela Poehlmann-Nitsche
Journal:  Oxid Med Cell Longev       Date:  2017-06-07       Impact factor: 6.543

7.  Topsentinol L Trisulfate, a Marine Natural Product That Targets Basal-like and Claudin-Low Breast Cancers.

Authors:  Nader N El-Chaar; Thomas E Smith; Gajendra Shrestha; Stephen R Piccolo; Mary Kay Harper; Ryan M Van Wagoner; Zhenyu Lu; Ashlee R Venancio; Chris M Ireland; Andrea H Bild; Philip J Moos
Journal:  Mar Drugs       Date:  2021-01-18       Impact factor: 5.118

8.  Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.

Authors:  Jarmila Herůdková; Kamil Paruch; Prashant Khirsariya; Karel Souček; Martin Krkoška; Olga Vondálová Blanářová; Petr Sova; Alois Kozubík; Alena Hyršlová Vaculová
Journal:  Neoplasia       Date:  2017-09-06       Impact factor: 5.715

9.  Identification of two ATR-dependent phosphorylation sites on coronavirus nucleocapsid protein with nonessential functions in viral replication and infectivity in cultured cells.

Authors:  Shouguo Fang; Linghui Xu; Mei Huang; Frank Qisheng Li; D X Liu
Journal:  Virology       Date:  2013-07-09       Impact factor: 3.616

10.  Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.

Authors:  Andrea Ghelli Luserna Di Rorà; Matteo Bocconcelli; Anna Ferrari; Carolina Terragna; Samantha Bruno; Enrica Imbrogno; Neil Beeharry; Valentina Robustelli; Martina Ghetti; Roberta Napolitano; Gabriella Chirumbolo; Giovanni Marconi; Cristina Papayannidis; Stefania Paolini; Chiara Sartor; Giorgia Simonetti; Timothy J Yen; Giovanni Martinelli
Journal:  Cancers (Basel)       Date:  2019-10-25       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.